← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Oryn Therapeutics, Llc
Vacaville, CA
$4,753,792
Total funding
2
Grants
Funding over time
peak $1.1M · FY2015–22$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,753,792 · 2
By mechanism
R44$4,753,792 · 2
Investigators at Oryn Therapeutics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
First-in-Class Macrocyclic Peptide Therapeutic For Rheumatoid Arthritis$1,142,534
R44 · FY2015 · AR
Cyclic Orynotides for Systemic MDR Candidiasis$998,632
R44 · FY2020 · AI
Cyclic Orynotides for Systemic MDR Candidiasis$991,551
R44 · FY2021 · AI
Cyclic Orynotides for Systemic MDR Candidiasis$983,348
R44 · FY2022 · AI
First-in-Class Macrocyclic Peptide Therapeutic For Rheumatoid Arthritis$352,749
R44 · FY2016 · AR
Cyclic Orynotides for Systemic MDR Candidiasis$284,978
R44 · FY2019 · AI